AlphaYouCJ
Insider selling
Christopher John Kenney sold $426K of Xenon Pharmaceuticals Inc. (XENE) stock
Christopher John Kenney, Chief Medical Officer of Xenon Pharmaceuticals Inc. (XENE), sold 7,068 shares of XENE stock worth $426K, per an SEC Form 4 filed Sep 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 28, 2026, 4 days before it was made public.
XENE has moved -35.0% since the trade date, from $59.99 to $38.99 (Sep 21, 2026 close).
- Traded
- Aug 28, 2026
- Disclosed
- Sep 1, 2026
- Filing delay
- 4 days
- Price since
- -35.0%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.